Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Saven

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Cancer|December 1, 1993
The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignanciesA Saven, L D Piro
Hematology and Cell Therapy|December 1, 1996
2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disordersA Saven, L D Piro
Leukemia & Lymphoma|January 1, 1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemiaA Saven, L D Piro
Hematology/Oncology Clinics of North America|April 1, 1994
Purine metabolism of lymphocytes. Targets for chemotherapy drug developmentC J Carrera, A Saven, L D Piro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphomaA Saven, T Lee, M Kosty, et al.
Leukemia & Lymphoma|January 1, 1994
The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemiaL D Piro, D J Ellison, A Saven
Annals of Internal Medicine|September 15, 1994
2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosisA Saven, K A Foon, L D Piro
Leukemia & Lymphoma|March 8, 2000
Treatment of hairy cell leukemia-variant with cladribineS A Tetreault, B A Robbins, A Saven
Southern Medical Journal|March 1, 1990
Dilutional acidosisD A Goodkin, R M Raja, A Saven
The New England Journal of Medicine|March 18, 1993
2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabineA Saven, R H Lemon, L D Piro
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancer|December 1, 1993
The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignanciesA Saven, L D Piro
Hematology and Cell Therapy|December 1, 1996
2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disordersA Saven, L D Piro
Leukemia & Lymphoma|January 1, 1993
2-Chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemiaA Saven, L D Piro
Hematology/Oncology Clinics of North America|April 1, 1994
Purine metabolism of lymphocytes. Targets for chemotherapy drug developmentC J Carrera, A Saven, L D Piro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphomaA Saven, T Lee, M Kosty, et al.
Leukemia & Lymphoma|January 1, 1994
The Scripps Clinic experience with 2-chlorodeoxyadenosine in the treatment of hairy cell leukemiaL D Piro, D J Ellison, A Saven
Annals of Internal Medicine|September 15, 1994
2-Chlorodeoxyadenosine-induced complete remissions in Langerhans-cell histiocytosisA Saven, K A Foon, L D Piro
Leukemia & Lymphoma|March 8, 2000
Treatment of hairy cell leukemia-variant with cladribineS A Tetreault, B A Robbins, A Saven
Southern Medical Journal|March 1, 1990
Dilutional acidosisD A Goodkin, R M Raja, A Saven
The New England Journal of Medicine|March 18, 1993
2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabineA Saven, R H Lemon, L D Piro
Pageof 7